Cargando…

Editorial: Head and neck cancer in the elderly

Detalles Bibliográficos
Autores principales:	Szturz, Petr, Vermorken, Jan B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325853/ https://www.ncbi.nlm.nih.gov/pubmed/37427107 http://dx.doi.org/10.3389/fonc.2023.1218274

Ejemplares similares

Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
por: Szturz, Petr, et al.
Publicado: (2016)

Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity
por: Szturz, Petr, et al.
Publicado: (2020)

Immunotherapy in head and neck cancer: aiming at EXTREME precision
por: Szturz, Petr, et al.
Publicado: (2017)

Translating KEYNOTE-048 into practice recommendations for head and neck cancer
por: Szturz, Petr, et al.
Publicado: (2020)

Editorial: Insights in head and neck cancer: 2021
por: Lybaert, Willem, et al.
Publicado: (2023)

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice
por: Szturz, Petr, et al.
Publicado: (2019)

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment
por: Vermorken, Jan B., et al.
Publicado: (2021)

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer
por: Szturz, Petr, et al.
Publicado: (2019)

Oligometastatic Disease Management: Finding the Sweet Spot
por: Szturz, Petr, et al.
Publicado: (2020)

Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond
por: Szturz, Petr, et al.
Publicado: (2021)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Women in head and neck cancer 2021
por: Economopoulou, Panagiota, et al.
Publicado: (2022)

Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty
por: de Bree, Remco, et al.
Publicado: (2022)

Steering decision making by terminology: oligometastatic versus argometastatic
por: Szturz, Petr, et al.
Publicado: (2022)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Next generation staging in head and neck cancers
por: Iyer, N. Gopalakrishna, et al.
Publicado: (2022)

Editorial: Challenges and their implications for the clinical practice of head and neck cancer
por: Wirth, Markus, et al.
Publicado: (2023)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Editorial: Prognosis prediction and risk stratification in head and neck cancer
por: Li, Tengxiang, et al.
Publicado: (2022)

Editorial: Head & Neck Cancer and Esophageal Cancer: From Biosignatures to Therapeutics
por: Kok, Victor C., et al.
Publicado: (2021)

Estimating the Prevalence of a True Oligometastatic Disease
por: Szturz, Petr, et al.
Publicado: (2022)

Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis
por: Henson, Christina E., et al.
Publicado: (2023)

Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
por: Leroy, Roos, et al.
Publicado: (2019)

Biologic Therapy in Head and Neck Cancer: A Road with Hurdles
por: Specenier, Pol, et al.
Publicado: (2012)

Cetuximab: its unique place in head and neck cancer treatment
por: Specenier, Pol, et al.
Publicado: (2013)

Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer
por: Argiris, Athanassios, et al.
Publicado: (2019)

The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy
por: Zaryouh, Hannah, et al.
Publicado: (2021)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

Palliative Care and End-of-Life Issues in Elderly Cancer Patients With Head and Neck Cancer
por: Schrijvers, Dirk, et al.
Publicado: (2022)

Editorial: “Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma”
por: Cao, Wei, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance
por: Amini, Arya, et al.
Publicado: (2014)

Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
por: Cristina, Valerie, et al.
Publicado: (2019)

Hypofractionated Radiotherapy in Head and Neck Cancer Elderly Patients: A Feasibility and Safety Systematic Review for the Clinician
por: Piras, Antonio, et al.
Publicado: (2021)

Editorial: Advances in the Involvement of Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma
por: Lechien, Jerome R., et al.
Publicado: (2022)

Effects of the COVID-19 pandemic on elderly patients with head and neck squamous cell carcinoma
por: Ye, Pei-Jing, et al.
Publicado: (2022)

Editorial: Virtual surgical planning and 3d printing in head and neck tumor resection and reconstruction
por: Su, Yu-xiong, et al.
Publicado: (2022)

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
por: Yang, Kai-Bin, et al.
Publicado: (2021)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck
por: Crombet Ramos, Tania, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l9p0397h53kmr26uqj9pmim5ol